ArticleScientific reports2025
Investigation of the production and antifungal properties of nanocapsules containing chamomile essential oil.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Our study aims to investigate the production of nanocapsules containing chamomile essential oil and assess their antifungal properties. We have developed a technological process for producing nanocapsules, selected chamomile raw materials, extracted the essential oil, and conducted research on the antimicrobial activity of nanocapsules against four fungal cultures: Candida albicans CGMCC 2.538, Aspergillus fumigatus CGMCC 3.5925, Trichophyton rubrum CGMCC 3.3777 and Epidermophyton floccosum CGMCC 3.3722. Our research revealed significant antimicrobial activity of chamomile-containing nanocapsules against all tested fungi. The zones of fungal inhibition varied depending on the oil concentration and were statistically significant (P < 0.05). The obtained results hold practical significance for the development of antimicrobial agents based on plant oils in the treatment of fungal infections. Further research may focus on the molecular mechanisms of chamomile oil's action, clinical trials in humans, and the optimization of nanocapsule formulations. These steps may contribute to the development of more effective and targeted antimicrobial agents for combating fungal infections and improving patient health.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.